-+ 0.00%
-+ 0.00%
-+ 0.00%

*Compass Therapeutics Ended 1Q With $113M in Cash and Marketable Securities, Which Is Expected to Provide Cash Runway Into the 1Q of 2027 >CMPX

Dow Jones·05/08/2025 12:01:00

Please log in to view news